captopril has been researched along with 2019 Novel Coronavirus Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y | 1 |
| Corrêa, BSG; da Silva, AA; de Barros, S; Furukawa, LNS; Peres, MA; Uchiyama, MK; Vaz, JB | 1 |
| Chen, L; Fan, W; Feng, L; Huang, X; Li, H; Li, P; Qu, L; Sun, J; Wang, J; Wang, Q; Yang, J; Zhang, S; Zhang, Y; Zhao, J | 1 |
| Biyani, CS; Daga, S; Palit, V | 1 |
| Dong, HY; Jia, L; Li, YM; Lin, M; Xie, HZ | 1 |
| Franco, R; Garrido-Gil, P; Labandeira, CM; Labandeira-Garcia, JL; Navarro, G; Pedrosa, MA; Rodriguez-Perez, AI; Valenzuela, R | 1 |
| Baka, T; Simko, F | 1 |
| Gao, WC; He, XY; Liu, FL; Ma, X; Wang, P; Zheng, CB; Zheng, YT | 1 |
8 other study(ies) available for captopril and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins | 2020 |
COVID-19: Understanding the impact of anti-hypertensive drugs and hydroxychloroquine on the ACE1 and ACE2 in lung and adipose tissue in SHR and WKY rats.
Topics: Adipose Tissue; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Pressure; Captopril; COVID-19; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Hypertension; Losartan; Lung; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; SARS-CoV-2 | 2023 |
SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Captopril; COVID-19; Humans; Inflammation; Mice; Myocytes, Cardiac; SARS-CoV-2 | 2023 |
The Use of Captopril-Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic.
Topics: Anesthesia; Betacoronavirus; Captopril; Cognition; Coronavirus Infections; COVID-19; Cystinuria; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Why do we lack a specific magic anti-COVID-19 drug? Analyses and solutions.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Captopril; Cardiovascular System; COVID-19; COVID-19 Drug Treatment; Drug Development; Drug Repositioning; Humans; Nebulizers and Vaporizers; Pharmaceutical Preparations; Respiratory System; SARS-CoV-2; Treatment Outcome | 2021 |
Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19.
Topics: ADAM17 Protein; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; COVID-19; COVID-19 Drug Treatment; Female; Humans; Lung; Male; Rats; Renin-Angiotensin System; SARS-CoV-2; Tetrazoles | 2021 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; COVID-19; Humans; Pandemics; Peptidyl-Dipeptidase A; Rats; Renin-Angiotensin System; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tetrazoles | 2021 |
Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; COVID-19; Gene Expression Regulation; Hypertension; Inflammation; Interleukin-1beta; Lung Diseases; Mice; SARS-CoV-2; Virus Replication | 2021 |